Optimizing Open Label Placebo Rationales
CompletedNot applicableNCT05952960
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
A 3-arm randomized trial where all chronic pain patients will receive honest placebos, but the information about the placebos will differ between conditions. Outcomes are measured for 21 days and a qualitative survey will be conducted.
Study details
- Official title
- Optimizing Open Label Placebo Rationales for Chronic Pain
- Conditions
- Interventions
- Sponsor
- Rhode Island Hospital
- Start date
- 2023-07-15
- Primary completion
- 2023-12-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronic pain * 18 years old * English speaking * have a smartphone or computer with video access * Taking prescription opioids for chronic pain * the chronic pain is concentrated into the patient's lower back. Exclusion Criteria: * suspect an allergy to any placebo ingredient * problematic substance use * cancer diagnosis causing pain * anticipated change in opioid script during the study period.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05952960